Why Applying Machine Learning to Biology is Hard – But Worth It



Jimmy Lin is CSO of Freenome, which is developing blood-based tests for early cancer detection, starting with colon cancer. He is a pioneer in developing computational approaches to extract insights from large-scale genomic data, having spearheaded the computational analyses of the first genome-wide sequencing studies in multiple cancer types.  Lin talked to Future about the... Read More

The post Why Applying Machine Learning to Biology is Hard – But Worth It appeared first on Future.